---
input_text: Pediatric Acute-on-Chronic Liver Failure. Acute-on-chronic liver failure
  (ACLF) is characterized by an acute hepatic insult happening in a patient with underlying
  cirrhosis with compromised hepatic reserve leading to development of systemic inflammation,
  sepsis, and organ failure resulting in poor outcome in majority. While Asia Pacific
  Association for Study of Liver Diseases (APASL) emphasizes on early diagnosis before
  development of organ failure, European Association for Study of Liver Diseases (EASL)
  mandates the presence of organ failures to define ACLF. There is a lack of consensus
  definition of pediatric ACLF although recent APASL guidelines have tried to address
  the issue. While Wilson disease (WD) and autoimmune hepatitis (AIH) are the most
  common cause of underlying cirrhosis in children, acute viral hepatitis and flares
  of WD and AIH are the commonest acute precipitating events. Poor outcomes [death
  and liver transplantation (LT)] ranging from 19 to 59% have been reported. Prognosis
  in pediatric ACLF is usually better than that in adults due to greater proportion
  of treatable etiologies, lesser organ failures, comorbidities and better hepatic
  reserves. APASL ACLF Research Consortium (AARC) score more than or equal to 11 is
  predictive of poor 28-90 d mortality. Treatment of pediatric ACLF relies mainly
  on prompt diagnosis and medical management of a potentially treatable etiology of
  underlying cirrhosis. Bridging therapies, especially high volume plasma exchange
  can be initiated early as a bridge to LT or native liver recovery. Those with no
  improvement in 4-7 d should undergo LT before development of sepsis or multi-organ
  failure.
raw_completion_output: |-
  primary_disease: Pediatric Acute-on-Chronic Liver Failure

  medical_actions: prompt diagnosis; medical management; bridging therapies; high volume plasma exchange; liver transplantation (LT)

  symptoms: systemic inflammation; sepsis; organ failure

  chemicals: 

  action_annotation_relationships: prompt diagnosis TREATS systemic inflammation IN Pediatric Acute-on-Chronic Liver Failure; medical management TREATS systemic inflammation IN Pediatric Acute-on-Chronic Liver Failure; bridging therapies (with high volume plasma exchange) TREATS organ failure IN Pediatric Acute-on-Chronic Liver Failure; liver transplantation (LT) TREATS organ failure IN Pediatric Acute-on-Chronic Liver Failure
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  liver transplantation (LT) TREATS organ failure IN Pediatric Acute-on-Chronic Liver Failure

  ===

extracted_object:
  primary_disease: Pediatric Acute-on-Chronic Liver Failure
  medical_actions:
    - prompt diagnosis
    - medical management
    - bridging therapies
    - high volume plasma exchange
    - MAXO:0001175
  symptoms:
    - systemic inflammation
    - HP:0100806
    - organ failure
  action_annotation_relationships:
    - subject: prompt diagnosis
      predicate: TREATS
      object: systemic inflammation
      qualifier: Pediatric Acute-on-Chronic Liver Failure
    - subject: medical management
      predicate: TREATS
      object: systemic inflammation
      qualifier: Pediatric Acute-on-Chronic Liver Failure
      subject_qualifier: <None>
      object_qualifier: <None>
      subject_extension: <None>
      object_extension: <None>
    - subject: <bridging therapies>
      predicate: <TREATS>
      object: <organ failure>
      qualifier: <Pediatric Acute-on-Chronic Liver Failure>
      subject_qualifier: <with high volume plasma exchange>
      subject_extension: <high volume plasma exchange>
    - subject: MAXO:0001175
      predicate: TREATS
      object: organ failure
      qualifier: Pediatric Acute-on-Chronic Liver Failure
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: liver transplantation
  - id: HP:0001695
    label: cardiac arrest
  - id: HP:0001685
    label: myocardial fibrosis
  - id: HP:0001663
    label: ventricular fibrillation
  - id: CHEBI:30703
    label: tetrathiomolybdate (TTM)
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0006554
    label: acute liver failure
  - id: HP:0003256
    label: coagulopathy
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: CHEBI:28694
    label: Copper
  - id: HP:0001395
    label: Liver fibrosis
  - id: HP:0001394
    label: Cirrhosis
  - id: CHEBI:39501
    label: trientine
  - id: CHEBI:27363
    label: zinc
  - id: HP:0001410
    label: hepatic dysfunction
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0000376
    label: Liver biopsy
  - id: HP:0001404
    label: Hepatocellular necrosis
  - id: CHEBI:61049
    label: Tacrolimus
  - id: CHEBI:50868
    label: Penicillamine
  - id: HP:0001744
    label: splenomegaly
  - id: HP:0001541
    label: ascites
  - id: HP:0001260
    label: Dysarthria
  - id: HP:0001347
    label: Hyperreflexia
  - id: HP:0031843
    label: Bradyphrenia
  - id: HP:0002362
    label: Shuffling gait
  - id: HP:0002300
    label: Mutism
  - id: HP:0001621
    label: Hypophonia
  - id: CHEBI:37153
    label: Calcineurin inhibitors
  - id: CHEBI:8356
    label: Pramipexole
  - id: CHEBI:2618
    label: Amantadine
  - id: HP:0001399
    label: liver failure
  - id: HP:0000952
    label: jaundice
  - id: HP:0001919
    label: acute kidney injury
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: MONDO:0013792
    label: Intracerebral Hemorrhage
  - id: HP:0001342
    label: Intracerebral Hemorrhage
  - id: MAXO:0000533
    label: Molecular genetic testing
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0002344
    label: worsening neurological symptoms
  - id: HP:0001272
    label: Cerebellar Atrophy
  - id: HP:0012896
    label: abnormal motor evoked potentials (MEPs)
  - id: HP:0001392
    label: liver disease
  - id: HP:0001396
    label: cholestasis
  - id: HP:0001403
    label: macrovesicular steatosis
  - id: CHEBI:8830
    label: rhodanine
  - id: CHEBI:90299
    label: orcein
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia (t-AML or AML-MRC)
  - id: CHEBI:41977
    label: Daunorubicin
  - id: CHEBI:28680
    label: Cytarabine
  - id: CHEBI:37404
    label: Elemental copper
  - id: CHEBI:16856
    label: Plasma glutathione (GSH)
  - id: CHEBI:53498
    label: Total antioxidant capacity (TAC)
  - id: CHEBI:566274
    label: Malondialdehyde (MDA)
  - id: CHEBI:33697
    label: RNAs
  - id: HP:0000989
    label: itchy skin
  - id: CHEBI:63623
    label: Dimercaptosuccinic acid
  - id: CHEBI:145810
    label: insulin
  - id: HP:0001250
    label: Epileptic seizures
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0002315
    label: Headache
  - id: CHEBI:6437
    label: Levetiracetam
  - id: HP:0002878
    label: Acute respiratory failure
  - id: CHEBI:166831
    label: copper chelating agents
  - id: MONDO:0004789
    label: Cholangitis
  - id: MAXO:0010026
    label: zinc supplementation
  - id: CHEBI:16796
    label: Melatonin
  - id: MAXO:0009095
    label: Zinc (Zn) therapy
  - id: MAXO:0001298
    label: therapy
  - id: CHEBI:38161
    label: Chelator
  - id: MONDO:0019542
    label: Acute Liver Failure (ALF)
  - id: HP:0002204
    label: Pulmonary embolism
  - id: HP:0100806
    label: Sepsis
  - id: HP:0001944
    label: dehydration
  - id: CHEBI:18248
    label: iron
  - id: CHEBI:18291
    label: manganese
  - id: CHEBI:22984
    label: calcium
  - id: HP:0001081
    label: Cholelithiasis
  - id: HP:0002716
    label: Lymphadenopathy
  - id: MONDO:0100193
    label: End-stage liver diseases
  - id: HP:0002040
    label: Esophageal varices
  - id: HP:0100626
    label: End-stage liver diseases
  - id: MONDO:0017014
    label: children
  - id: MAXO:0009016
    label: Botulinum toxin type A (BoNT-A) injection
  - id: CHEBI:3160
    label: Botulinum toxin type A (BoNT-A)
  - id: HP:0003088
    label: Premature osteoarthritis
  - id: HP:0002885
    label: Mallory-Denk body (MDB) formation
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:16990
    label: Bilirubin
  - id: MONDO:0100192
    label: Liver failure
  - id: HP:0001409
    label: Portal hypertension
  - id: HP:0001402
    label: Hepatocellular carcinoma
  - id: CHEBI:30663
    label: Serum ceruloplasmin (CP)
  - id: HP:0001513
    label: obesity
  - id: CHEBI:16610
    label: spermidine
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:15351
    label: AcCoA
